Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Vaccine Dose Finding Pilot Study for Development of an Anti-Influenza A (H5N1) Intravenous Hyper-Immune Globulin

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00383071
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:51.177098+00:00
Published At
2013-05-27T00:00:00+00:00
Record Updated At
2018-07-31
Results Posted At
2013-05-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Infectious Diseases", "Influenza", "Avian Flu"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-07-31"
protocolSection.identificationModule.nctId
"NCT00383071"
protocolSection.identificationModule.officialTitle
"A Phase II Vaccine Dose Finding Pilot Study for Development of an Anti-Influenza A (H5N1) Intravenous Hyper-Immune Globulin"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2013-05-27"

Study condition terms

  • Infectious Diseases (protocolSection.conditionsModule.conditions)
  • Influenza (protocolSection.conditionsModule.conditions)
  • Avian Flu (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.